Organization · Family Office
Lightchain Capital LLC
Lightchain Capital LLC is a single-family office venture capital fund based in St. Louis, Missouri, focusing on early-stage life sciences companies, particularly in cancer therapeutics and diagnostics.
Overview
What Lightchain Capital LLC does
What Lightchain Capital LLC is
Lightchain Capital LLC is a single-family office venture capital fund based in St. Louis, Missouri, focusing on early-stage life sciences companies, particularly in cancer therapeutics and diagnostics.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find Lightchain Capital LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Lightchain Capital LLC as a funder
Investment thesis
Lightchain Capital aims to accelerate viable scientific investments that improve outcomes for cancer patients, particularly focusing on multiple myeloma and related blood cancers.
Focus narrative
Lightchain Capital primarily invests in early-stage life sciences and software companies, with a strong emphasis on cancer therapeutics and diagnostics. The fund seeks opportunities in companies that require multiple rounds of financing and collaboration, aiming to support innovations that can significantly impact cancer treatment and patient care.
Value beyond capital
Lightchain Capital adds value to its portfolio companies through active engagement, including tracking board appointments, trial data, and partnerships. The fund's mission-driven approach ensures that investments are not only financially sound but also aligned with improving cancer treatment outcomes.
Terms and economics
- Typical check
- $23,000,000–$115,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Series C+
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 7
- Recorded notable exits
- Scottrade
Portfolio context
Notable portfolio companies include: C4 Therapeutics, Inc.: A clinical-stage biopharmaceutical company focused on developing small-molecule medicines that selectively degrade disease-causing proteins. Geneoscopy, Inc.: A life sciences company developing non-invasive diagnostics for gastrointestinal diseases, including cancer screening. NextRNA Therapeutics: A biotechnology company working on RNA-targeted therapeutics. Wugen: A clinical-stage biotechnology company developing universal natural killer and T-cell therapies for cancer treatment. CareVet: A veterinary practice management group managing hospitals across the U.S. AI Proteins: A company focused on designing new proteins for therapeutic functions using AI-based methods. Simple Rose: A company providing applications for scheduling, production planning, and portfolio optimization.
Common questions
What to know about Lightchain Capital LLC
Upseed classifies Lightchain Capital LLC under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.